This week, Russian Federation approved a vaccine even before it started the last phase of clinical trials. Multiple clinical studies of different vaccines are already underway, and a challenge trial is not likely to replace them, the National Institute of Allergy and Infectious Diseases (NIAID) told Reuters.
Daily infections in Victoria peaked at 725 on August 5 and have been trending lower in recent days, following the imposition of a hard lockdown in Melbourne on July 19. The state, home to the city of Melbourne which has been the epicentre of the latest outbreak, also recorded eight deaths over the past 24 hours. Premier Daniel Andrews said the Australian Defence Force had not been on offer to guard the hotels when the scheme began.
Under the new system, the United Kingdom government and the devolved administrations have agreed to publish the number of deaths that occurred within 28 days of a positive lab-confirmed Covid test result on a daily basis. It brings the total number of coronavirus deaths in United Kingdom hospitals to 34,076 since the start of the outbreak. Professor Keith Neal, Emeritus Professor of the epidemiology of infectious diseases at the University of Nottingham, said if the data error had not been ...
Australia's daily COVID-19-related death toll hit a new record high on Wednesday with 21 fatalities in the past 24 hours all reported in the state of Victoria, German news agency, dpa, reported. Victorian authorities had warned deaths would continue to rise given the number of people in hospital with the virus. Andrews also indicated that there was a "concerning increase" of COVID-19 cases in the regional cities of Geelong, Bendigo and Ballarat.
Russian Federation says their Covid 19 vaccine emerged from the research it did on Ebola vaccines it developed in 2015 and 2018. The chief of Russia´s sovereign wealth fund, which is financing and helping to coordinate the vaccine efforts, told reporters that Phase 3 trials would start on Wednesday.
Russia's rapid pace "highlights its determination to win the global race" for a vaccine but "has stirred concerns that it may be putting national prestige before science and safety", Reuters points out. has a number of vaccines in development, "if we wanted to take the chance of hurting a lot of people or giving them something that doesn't work, we could start doing this, you know, next week if we wanted to".